Halozyme Therapeutics (HALO) – Analyst EPS View
-
Halozyme Therapeutics (HALO) PT Raised to $66 at BMO Capital
-
Halozyme Therapeutics (HALO) PT Lowered to $19 at BMO Capital
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to HALO Stock Lookup